These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 31228861)

  • 41. Effect of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Use, and Diabetes Medication Costs Among Individuals with Type 2 Diabetes Mellitus.
    Raval AD; Nguyen MH; Zhou S; Grabner M; Barron J; Quimbo R
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1111-1123. PubMed ID: 31556817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitus.
    Brancato D; Fleres M; Aiello V; Saura G; Scorsone A; Ferrara L; Provenzano F; Di Noto A; Spano L; Provenzano V
    Diabetes Technol Ther; 2014 Nov; 16(11):735-41. PubMed ID: 25162664
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical value of Flash glucose monitoring in patients with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Moreno-Fernandez J; Pazos-Couselo M; González-Rodriguez M; Rozas P; Delgado M; Aguirre M; Garcia-Lopez JM
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):556-563. PubMed ID: 29907546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and Safety of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Injections on Type 1 Diabetes Children: A Meta-Analysis of Randomized Control Trials.
    Qin Y; Yang LH; Huang XL; Chen XH; Yao H
    J Clin Res Pediatr Endocrinol; 2018 Nov; 10(4):316-323. PubMed ID: 30015622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.
    Buse JB; Kudva YC; Battelino T; Davis SN; Shin J; Welsh JB
    Diabetes Technol Ther; 2012 Jul; 14(7):644-7. PubMed ID: 22524549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
    Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
    JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Continuous intraperitoneal insulin infusion versus subcutaneous insulin therapy in the treatment of type 1 diabetes: effects on glycemic variability.
    van Dijk PR; Groenier KH; DeVries JH; Gans RO; Kleefstra N; Bilo HJ; Logtenberg SJ
    Diabetes Technol Ther; 2015 Jun; 17(6):379-84. PubMed ID: 25856045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
    Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
    J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of biomarkers of inflammation and premature atherosclerosis in adolescents with type-1 diabetes mellitus.
    Babar G; Clements M; Dai H; Raghuveer G
    J Pediatr Endocrinol Metab; 2019 Feb; 32(2):109-113. PubMed ID: 30710485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus.
    Breton MD; Patek SD; Lv D; Schertz E; Robic J; Pinnata J; Kollar L; Barnett C; Wakeman C; Oliveri M; Fabris C; Chernavvsky D; Kovatchev BP; Anderson SM
    Diabetes Technol Ther; 2018 Aug; 20(8):531-540. PubMed ID: 29979618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Sensor-Augmented Pump Treatment Versus Multiple Daily Injections on Albuminuria: A 1-Year Randomized Study.
    Rosenlund S; Hansen TW; Rossing P; Andersen S
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4181-8. PubMed ID: 26390102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Increased arterial stiffness in childhood onset diabetes: a cardiovascular magnetic resonance study.
    Heier M; Stensæth KH; Brunborg C; Seljeflot I; Margeirsdottir HD; Hanssen KF; Dahl-Jørgensen K
    Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):694-700. PubMed ID: 28950341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
    Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
    Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.
    Sulli N; Shashaj B
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):393-9. PubMed ID: 12705364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Arterial Stiffness Is Positively Associated With 18F-fluorodeoxyglucose Positron Emission Tomography-Assessed Subclinical Vascular Inflammation in People With Early Type 2 Diabetes.
    de Boer SA; Hovinga-de Boer MC; Heerspink HJ; Lefrandt JD; van Roon AM; Lutgers HL; Glaudemans AW; Kamphuisen PW; Slart RH; Mulder DJ
    Diabetes Care; 2016 Aug; 39(8):1440-7. PubMed ID: 27281773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin therapy in children and adolescents with type 1 diabetes.
    Malik FS; Taplin CE
    Paediatr Drugs; 2014 Apr; 16(2):141-50. PubMed ID: 24458650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes.
    Phelan H; Clapin H; Bruns L; Cameron FJ; Cotterill AM; Couper JJ; Davis EA; Donaghue KC; Jefferies CA; King BR; Sinnott RO; Tham EB; Wales JK; Jones TW; Craig ME
    Med J Aust; 2017 Feb; 206(3):121-125. PubMed ID: 28208043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.